Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
Product Unit Size | Cost | Quantity | Stock |
---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
Cas No. | 2170137-61-6 (free base) |
---|---|
Purity | ≥98% |
Formula | C16H25N5 |
Formula Wt. | 287.41 |
IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
Synonym | KB0742, NSC-834161, NSC834161 |
Appearance | Yellow to brown crystal |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Peptide; GABA potentiator, NMDA negative allost...
Mycotoxin produced by various fungi including t...
PDGFR inhibitor.
Endogenous APP peptide cleavage product, primar...
Abl (T315I) inhibitor.
CDK inhibitor, L-type Ca2+ channel blocker.
Pyrimidine nucleoside base, pairs with adenosin...
CDK9 inhibitor.
Butyrophenone; α-adrenergic, D2, histamine ant...
Isoquinoline alkaloid found in a variety of pla...
AMPK activator.
Bisphosphonate, chelating agent.
Endogenous hormone neurotransmitter, involved i...
Nucleoside (guanosine) analog; DNA chain termin...
Retinol (vitamin A) analog, binds RBP4; Des1 in...
Casein kinase 1 inhibitor.
PI3K and mTOR inhibitor.
Inhibitor of PTEFb/CDK9.
Nucleoside (guanosine) analog; DNA chain termin...
Found in Streptomyces; proteasome inhibitor.